ACE inhibitor reduces the incidence of atrial fibrillation in post-myocardial infarction patients.
- Published in:
- Formulary, 1999, v. 34, n. 10, p. 877
- Publication type:
- Article
Works matching IS 1082801X AND DT 1999 AND VI 34 AND IP 10
Results: 15
1
2
Antibacterial agents.
- Published in:
- Formulary, 1999, v. 34, n. 10, p. 880
- Publication type:
- Article
3
Controversy over prescription drug advertising stimulates policy changes.
- Published in:
- Formulary, 1999, v. 34, n. 10, p. 878
- By:
- Publication type:
- Article
4
Toward the rational use of antibiotics in the intensive care unit.
- Published in:
- Formulary, 1999, v. 34, n. 10, p. 836
- By:
- Publication type:
- Article
5
Cigarette smoking: Its effects on warfarin dosing and on the pk of warfarin enantiomers.
- Published in:
- Formulary, 1999, v. 34, n. 10, p. 873
- Publication type:
- Article
6
Antibiotic monitoring program improves use, reduces cost.
- Published in:
- Formulary, 1999, v. 34, n. 10, p. 873
- Publication type:
- Article
7
Case management of depression by clinical pharmacists in a primary care setting.
- Published in:
- Formulary, 1999, v. 34, n. 10, p. 864
- By:
- Publication type:
- Article
8
A strategy for evaluating the novel COX-2 inhibitors versus NSAIDs for arthritis.
- Published in:
- Formulary, 1999, v. 34, n. 10, p. 855
- By:
- Publication type:
- Article
9
Tenecteplase shows equivalent 30-day mortality to alteplase.
- Published in:
- Formulary, 1999, v. 34, n. 10, p. 877
- Publication type:
- Article
10
Rosiglitazone: A new thiazolidinedione for treatment of type 2 diabetes.
- Published in:
- Formulary, 1999, v. 34, n. 10, p. 825
- By:
- Publication type:
- Article
11
Latanoprost more effective, often better tolerated than other glaucoma regimens, studies find.
- Published in:
- Formulary, 1999, v. 34, n. 10, p. 822
- Publication type:
- Article
12
Test identifies patients who will benefit from tirofiban.
- Published in:
- Formulary, 1999, v. 34, n. 10, p. 820
- Publication type:
- Article
13
Investigational 'triptan' improves 2-hour headache response compared with oral sumatriptan.
- Published in:
- Formulary, 1999, v. 34, n. 10, p. 819
- Publication type:
- Article
14
Widespread ACE inhibitor use justified in vascular disease, HOPE study reveals.
- Published in:
- Formulary, 1999, v. 34, n. 10, p. 819
- Publication type:
- Article
15
FDA drug approvals.
- Published in:
- Formulary, 1999, v. 34, n. 10, p. 808
- Publication type:
- Article